Skip to main content
. 2025 Oct 31;15(11):1533. doi: 10.3390/biom15111533
MM Multiple myeloma
IMiDs Immunomodulatory drugs
TE Thrombotic events
LMWH Low molecular weight heparin
Thal Thalidomide
Len Lenalidomide
Pom Pomalidomide
VTE Venous thromboembolism
β2M Beta-2 microglobulin
IMWG International Myeloma Working Group
SA-PE Streptavidin-phycoerythrin
ASA Aspirin
MLR Monocyte-to-lymphocyte ratio
DOAC Direct oral anticoagulants